<?xml version="1.0" encoding="UTF-8"?>
<ref id="B65">
 <label>65.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De</surname>
    <given-names>Santis O</given-names>
   </name>
   <name>
    <surname>Audran</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Pothin</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Warpelin-Decrausaz</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Vallotton</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Wuerzner</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study</article-title>. 
  <source>Lancet Infect Dis.</source> (
  <year>2016</year>) 
  <volume>16</volume>:
  <fpage>311</fpage>â€“
  <lpage>20</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(15)00486-7</pub-id>
  <?supplied-pmid 26725450?>
  <pub-id pub-id-type="pmid">26725450</pub-id>
 </mixed-citation>
</ref>
